Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Mylan
Mylan
Page 5 of 6
Health
Lawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By
Sy Mukherjee
August 23, 2016
Health
How Mylan Got Away With Its Enormous Price Hike for the EpiPen
By
Sy Mukherjee
August 22, 2016
Health
How Mylan Is Taking On One of the World’s Top Breast Cancer Drugs
By
Sy Mukherjee
June 5, 2016
Finance
Here’s Why Mylan’s Stock Plunged
By
Jen Wieczner
February 12, 2016
Health
Mylan Reaches $7.2 Billion Deal for Meda
By
Laura Lorenzetti
February 10, 2016
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By
Jen Wieczner
November 13, 2015
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By
Jeffrey Sonnenfeld
November 13, 2015
Health
Mylan’s Hostile Bid for Perrigo Fails
By
Reuters
November 13, 2015
MPW
Mylan CEO Heather Bresch: We needed tax inversion in order to grow
By
Jen Wieczner
October 14, 2015
Finance
Why this pharma CEO bought his arch-rival’s stock
By
Jen Wieczner
September 18, 2015
Leadership
Blurred governance: Mylan’s illusions vs. BofA’s realities
By
Jeffrey Sonnenfeld
September 15, 2015
MPW
Why Wall Street loves to hate Mylan’s CEO
By
Jen Wieczner
September 11, 2015
Finance
This drug-industry deal would be the largest hostile takeover in history
By
Jen Wieczner
September 8, 2015
Features
Google/E.U. and Walmart’s holiday sales — 5 things to know today
By
Tom Huddleston Jr.
and
Geoffrey Smith
August 28, 2015
Features
Stocks, economic growth, and a Fed conference — 5 things to know this week
By
Tom Huddleston Jr.
August 23, 2015
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore
Economy
America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
By
Eleanor Pringle